Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Revenue of Bliss GVS Pharma Limited (BLISSGVS.NS)
Revenue in 2023 (TTM): $91.22 M
According to Bliss GVS Pharma Limited's latest financial reports the company's current revenue (TTM) is $91.22 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Bliss GVS Pharma Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $91.22 M | $43.77 M | $17.52 M | $13.84 M | $8.94 M |
| 2022 | $89.01 M | $41.48 M | $16 M | $12.56 M | $8.39 M |
| 2021 | $87.39 M | $41.09 M | $9.03 M | $6.41 M | $1.78 M |
| 2020 | $67.35 M | $28.4 M | $15.03 M | $12.33 M | $8.11 M |
| 2019 | $80.76 M | $28.65 M | $17.66 M | $15.27 M | $11.52 M |
| 2018 | $104.94 M | $32.43 M | $23.13 M | $21.54 M | $14.65 M |
| 2017 | $43.09 M | $20.09 M | $9.67 M | $7.58 M | $6.96 M |
| 2016 | $94.71 M | $52.16 M | $13.25 M | $21.22 M | $10.14 M |
| 2015 | $64.77 M | $34.36 M | $21.17 M | $17.55 M | $9.77 M |
| 2014 | $48.22 M | $27.19 M | $14.65 M | $11.37 M | $7.1 M |
| 2013 | $41.08 M | $20.87 M | $8.76 M | $8.36 M | $4.85 M |
| 2012 | $46.97 M | $22.84 M | $13.11 M | $12.97 M | $6.84 M |
| 2011 | $31.58 M | $12.93 M | $10.31 M | $9.41 M | $6.22 M |
| 2010 | $25.92 M | $10.83 M | $-3,365,022 | $6.27 M | $4.81 M |
| 2009 | $20 M | $9.27 M | $6.36 M | $5.42 M | $4.94 M |
| 2008 | $15.75 M | $7.47 M | $5.46 M | $4.77 M | $4.44 M |
| 2007 | $12.13 M | $6.85 M | $4.68 M | $4.17 M | $4 M |
| 2006 | $7.38 M | $3.16 M | $1.12 M | $694.44 K | $454.88 K |